Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
0001193125-17-350721.pdf 0001193125-17-350721.rtf 0001193125-17-350721.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
SEARS SAMUEL P JR 0000899243-17-026806.pdf 0000899243-17-026806.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-347122.pdf 0001193125-17-347122.rtf 0001193125-17-347122.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-340971.pdf 0001193125-17-340971.rtf 0001193125-17-340971.xls View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
0001193125-17-338909.pdf 0001193125-17-338909.rtf 0001193125-17-338909.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
0001193125-17-329699.pdf 0001193125-17-329699.rtf 0001193125-17-329699.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-308857.pdf 0001193125-17-308857.rtf 0001193125-17-308857.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-305998.pdf 0001193125-17-305998.rtf 0001193125-17-305998.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-17-022447.pdf 0000899243-17-022447.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-17-282839.pdf 0001193125-17-282839.rtf 0001193125-17-282839.xls View HTML

Copyright Morningstar